Ocular neuroprotection by siRNA targeting caspase-2

Z Ahmed1, H Kalinski, M Berry

  • 1Neuropharmacology and Neurobiology Section, School of Clinical and Experimental Medicine, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK. z.ahmed.1@bham.ac.uk

Cell Death & Disease
|June 17, 2011
PubMed
Summary

Inhibition of caspase-2, a key enzyme in retinal ganglion cell (RGC) death after optic nerve injury, using synthetic short interfering ribonucleic acid (siRNA) promotes RGC survival. This finding offers a potential neuroprotective strategy for ophthalmic diseases causing RGC loss.